Can Fite Biopharma Ltd ADR (CANF) — Financial Flexibility Index
Can Fite Biopharma Ltd ADR (CANF) has a Financial Flexibility Index of -0.67x as of June 2025. Free cash flow of $-2.38 Million (operating CF $-2.38 Million minus capex $500.00) represents -1% of total liabilities ($3.54 Million). Check Can Fite Biopharma Ltd ADR investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Can Fite Biopharma Ltd ADR Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Can Fite Biopharma Ltd ADR across 15 annual periods. For the full cash flow conversion analysis, see Can Fite Biopharma Ltd ADR cash flow conversion.
Annual Financial Flexibility Index for Can Fite Biopharma Ltd ADR (2011–2025)
Year-by-year free cash flow to debt coverage for Can Fite Biopharma Ltd ADR. Explore how well can Can Fite Biopharma Ltd ADR service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.30x | $-9.02 Million | $-9.02 Million | $3.92 Million | ▼ -11.0% |
| 2024 | -2.07x | $-7.63 Million | $-7.64 Million | $3.68 Million | ▲ +8.0% |
| 2023 | -2.25x | $-8.44 Million | $-8.44 Million | $3.75 Million | ▼ -0.4% |
| 2022 | -2.24x | $-10.79 Million | $-10.80 Million | $4.81 Million | ▼ -33.7% |
| 2021 | -1.68x | $-9.85 Million | $-9.86 Million | $5.87 Million | ▲ +51.9% |
| 2020 | -3.49x | $-12.04 Million | $-12.06 Million | $3.45 Million | ▼ -84.7% |
| 2019 | -1.89x | $-10.83 Million | $-10.83 Million | $5.73 Million | ▼ -126.3% |
| 2018 | -0.83x | $-4.12 Million | $-4.16 Million | $4.94 Million | ▲ +58.1% |
| 2017 | -1.99x | $-9.52 Million | $-9.52 Million | $4.78 Million | ▼ -40.5% |
| 2016 | -1.42x | $-8.92 Million | $-8.93 Million | $6.29 Million | ▼ -120.1% |
| 2015 | -0.64x | $-4.61 Million | $-4.65 Million | $7.16 Million | ▲ +70.7% |
| 2014 | -2.20x | $-7.32 Million | $-7.33 Million | $3.33 Million | ▲ +44.5% |
| 2013 | -3.96x | $-8.62 Million | $-8.63 Million | $2.18 Million | ▼ -113.6% |
| 2012 | -1.85x | $-4.34 Million | $-4.35 Million | $2.34 Million | ▲ +45.4% |
| 2011 | -3.40x | $-5.47 Million | $-5.50 Million | $1.61 Million | — |